• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives 2-halopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines 2-halopyridines

Recent Advances in the Application of 2-Bromo-5-methylpyridine 1-oxide (CAS: 19230-58-1) in Chemical Biology and Pharmaceutical Research

2-Bromo-5-methylpyridine 1-oxide (CAS: 19230-58-1) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial intermediate in the synthesis of various bioactive molecules, including potential drug candidates. The unique structural features of 2-Bromo-5-methylpyridine 1-oxide, such as its bromine substituent and N-oxide moiety, make it a valuable building block for the development of novel therapeutic agents. Recent studies have explored its utility in medicinal chemistry, particularly in the design of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds.

One of the most notable advancements in the application of 2-Bromo-5-methylpyridine 1-oxide is its role in the synthesis of kinase inhibitors. Kinases are key regulators of cellular signaling pathways and are often implicated in diseases such as cancer and autoimmune disorders. Researchers have successfully utilized 2-Bromo-5-methylpyridine 1-oxide as a precursor to develop selective kinase inhibitors with improved potency and reduced off-target effects. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in the synthesis of novel JAK2 inhibitors, which show promise for the treatment of myeloproliferative neoplasms.

In addition to its applications in kinase inhibitor development, 2-Bromo-5-methylpyridine 1-oxide has also been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters highlighted the compound's potential as a scaffold for designing new antibacterial agents. The study reported that derivatives of 2-Bromo-5-methylpyridine 1-oxide exhibited significant activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). These findings underscore the compound's potential in addressing the growing challenge of antibiotic resistance.

Another area of research where 2-Bromo-5-methylpyridine 1-oxide has shown promise is in the development of anti-inflammatory agents. A 2022 study in the European Journal of Medicinal Chemistry explored the anti-inflammatory effects of 2-Bromo-5-methylpyridine 1-oxide derivatives in vitro and in vivo. The researchers found that certain derivatives effectively inhibited the production of pro-inflammatory cytokines, such as TNF-α and IL-6, suggesting their potential as therapeutic agents for inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease.

Despite these promising developments, challenges remain in the optimization of 2-Bromo-5-methylpyridine 1-oxide-based compounds for clinical use. Issues such as bioavailability, metabolic stability, and toxicity profiles need to be addressed through further research. However, the compound's versatility and the growing body of evidence supporting its applications in drug discovery make it a valuable tool for medicinal chemists. Future studies are expected to explore new synthetic routes and derivatives of 2-Bromo-5-methylpyridine 1-oxide, as well as their potential in targeting other disease pathways.

In conclusion, 2-Bromo-5-methylpyridine 1-oxide (CAS: 19230-58-1) continues to be a focal point in chemical biology and pharmaceutical research. Its applications in the synthesis of kinase inhibitors, antimicrobial agents, and anti-inflammatory compounds highlight its broad utility in drug discovery. As research progresses, this compound is likely to play an increasingly important role in the development of novel therapeutics for a range of diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)